Abbott Laboratories

Entry	Author	Date	Location
What Are the Hottest Targets in Biotech Today?	Luke Timmerman	04/23/12	National
Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1	Luke Timmerman	04/16/12	National
Wayne State Hires Former Pharma Exec to Lead Tech Commercialization Efforts	Sarah Schmid	02/02/12	Detroit
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition	Luke Timmerman	12/15/11	Boston
ImmusanT, Developing Celiac Disease Treatments, Closes $20M Series A	Erin Kutz	12/13/11	Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500	Luke Timmerman	12/12/11	National
The Cancer Drug Dark Ages Are Coming to an End	Luke Timmerman	10/31/11	National
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News	Luke Timmerman	10/06/11	Seattle
Cardiac Dimensions Wins EU Approval for Heart Failure Device, Aims for Market in 2012	Luke Timmerman	09/29/11	Seattle
Crescendo Bioscience Nabs $56M to Help Personalize Rheumatoid Arthritis Therapy	Luke Timmerman	09/08/11	San Francisco
Allozyne’s Backdoor IPO, Sound Pharma Fights iPod Deafness, Mirina Vs. Marina Ends, & More Seattle-Area Life Sciences News	Luke Timmerman	06/23/11	Seattle
Alder Gets $15M From Bristol	Luke Timmerman	06/20/11	Seattle
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News	Erin Kutz	06/10/11	Boston
BMS & Others Partner with WPI	Erin Kutz	06/09/11	Boston
Orexigen, Facing High Hurdle at FDA, Puts Obesity Drug Development on Hold; Shares Tank	Luke Timmerman	06/03/11	San Diego
AVI Biopharma CEO Chris Garabedian Seeks to Avoid Quick Flip, Build Enduring Drug Company	Luke Timmerman	06/02/11	Seattle
SpringLeaf Snags $15M for New Self-Injection System for Biotech Drugs	Luke Timmerman	05/12/11	Boston
Roche Vet Takes CEO Job at Boston’s Enlight Biosciences	Ryan McBride	04/12/11	Boston
SeaGen Strikes Abbott Deal, Omeros Passes Study, Alnylam Fires Back at Tekmira, & More Seattle-Area Life Sciences News	Luke Timmerman	03/24/11	Seattle
SeaGen Inks Abbott Deal	Luke Timmerman	03/22/11	Seattle
Quanterix, Novartis Test Out Super-Sensitive Diagnostic Tool for Neuro Disorder	Luke Timmerman	02/22/11	Boston
CalciMedica Moves Psoriasis Drug Into Clinic, Pockets $6M	Luke Timmerman	02/17/11	San Diego
Arena Pharmaceuticals Axes One-Fourth of Workforce As it Hangs On With Obesity Drug	Luke Timmerman	01/27/11	San Diego
Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug	Luke Timmerman	01/21/11	San Diego
Entrega Emerges From Enlight	Gregory T. Huang	01/10/11	Boston
How VCs Use Advice from Experts	John Steuart	12/23/10	San Francisco
Orexigen Beats the Odds, Wins OK from FDA Panel for Obesity Drug	Luke Timmerman	12/07/10	San Diego
The Fight Against Diabesity: How Will San Diego Adapt in the Era of Tough FDA Scrutiny?	Luke Timmerman	11/22/10	San Diego
Complete Genomics Goes Public, 23andMe Raises $22M, Genomic Health’s Dx Vision, & More Bay Area Life Sciences News	Luke Timmerman	11/12/10	San Francisco
Genzyme Initiates Job Cuts, Dana-Farber/Gatekeeper Suit Advances, GTC Bought by LFB, & More Boston-Area Life Sciences News	Erin Kutz	11/12/10	Boston
Page 1 of 3	next page »

Entry

Author

Date

Location

What Are the Hottest Targets in Biotech Today?

Luke Timmerman

04/23/12

National

Abbott’s Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1

Luke Timmerman

04/16/12

National